•   
  •   
  •   

World You Can Now Get a COVID-19 Vaccine in China. That Might Not Be a Good Thing

09:26  22 october  2020
09:26  22 october  2020 Source:   time.com

COVID Vaccine Update as Johnson & Johnson Trial Suffers Setback, Sanofi Aims for Mid-2021 Rollout

  COVID Vaccine Update as Johnson & Johnson Trial Suffers Setback, Sanofi Aims for Mid-2021 Rollout There may be "up to 100 million doses" of a COVID-19 vaccine available by the end of the year, U.S. Secretary of Health and Human Services Alex Azar stated last week.On Monday, U.S.-based Johnson & Johnson announced a pause on all of its COVID-19 vaccine candidate clinical trials due to an "unexplained illness" in one of its study participants.

Not everyone in China will need to get vaccinated against Covid - 19 , according to the country's top medical official, as Beijing looks to prioritize frontline China 's reported virus numbers have stayed low since the spring. There have been a few flare-ups -- clusters in the northeastern Jilin province in May

But some have a better shot than others. Here’s One Idea. A weighted lottery gives everyone a chance at a drug or vaccine in short supply. But getting that data would be more complicated, because vaccine distribution may involve tens of millions of people.

Li Shurui didn’t hesitate. Faced with putting his life on hold indefinitely or the risk of catching COVID-19 by returning to university in the U.K., the 22-year-old business student decided to roll up his sleeve and receive an experimental coronavirus vaccine.

a man standing in a kitchen: A staff member works during a media tour of a new factory built to produce a COVID-19 coronavirus vaccine at Sinovac, one of 11 Chinese companies approved to carry out clinical trials of potential coronavirus vaccines, in Beijing on September 24, 2020. © Wang Zhao–AFP/Getty Images A staff member works during a media tour of a new factory built to produce a COVID-19 coronavirus vaccine at Sinovac, one of 11 Chinese companies approved to carry out clinical trials of potential coronavirus vaccines, in Beijing on September 24, 2020.

Two injections made by Beijing Kexing Biological cost 2,000 rmb ($300) at the private Taihe Hospital in the Chinese capital. The treatment still hasn’t passed final (Stage 3) clinical trials but is already being offered to the public on a first come, first served basis. Anyone can turn up, pay their money and get the jab. Li says hundreds were queuing to get immunized at the same time as him.

Protecting the profits of a few could prevent vaccine access for all

  Protecting the profits of a few could prevent vaccine access for all India and South Africa have put forward a novel proposal to replace our current competition-driven approach with cooperation. At a meeting on Oct. 15, they will be asking the World Trade Organization (WTO) to temporarily relax its rules to allow for more international collaboration in the manufacture of the vaccines and medicines - even without authorization from the companies that created them. Theirs is an ambitious gambit, but one that deserves support. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.

Researchers will now push forward, testing the vaccine 's efficiency, and prepping it for registration with the Health Ministry. Other prototypes are to follow, with some about to finish phase-one trials – which usually demonstrates the It's fairly easy to grasp why Russia is so keen to get a Covid - 19 vaccine .

to prepare for a Covid - 19 vaccine rollout by deputizing trusted community leaders to “reduce vaccine hesitancy,” bemoaning the rapid spread of or annotate things that actually cause huge damage, like not wearing masks or not being willing to take the vaccine if it proves that it is this key tool to getting

“I’m a little worried about side effects but more worried catching the virus overseas,” Li tells TIME. “But I haven’t had any problems from the jabs so far.”

It’s not just the Kexing vaccine on offer in China. An unofficial vaccine rollout is gathering pace despite the warnings of international public health experts. In September, state-owned SinoPharm revealed that hundreds of thousands of Chinese had already taken its experimental COVID-19 vaccines as part of a state initiative to protect frontline health workers and officials traveling to high-risk nations. In the eastern manufacturing hub of Yiwu this week, hundreds of people queued for a $60 dose of the CoronaVac vaccine made by private firm SinoVac.

Read more: ‘We Will Share Our Vaccine with the World.’ Inside the Chinese Biotech Firm Leading the Fight Against COVID-19

Legacy Museum reopens, Hawaii gets visitors, Boston Symphony Orchestra

  Legacy Museum reopens, Hawaii gets visitors, Boston Symphony Orchestra How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

The Chinese city of Qingdao is testing its entire population of nine million people for Covid - 19 over a period of five days. The mass testing comes after the discovery of a They were not known to have infected anyone else. Daily coronavirus infections have fallen drastically in China , and for the most

The new coronavirus - known as COVID - 19 - has killed at least 2,663 and infected more than 77,660 people inside China . Two men wearing face Last month, a Russian diplomatic mission in China said that Russia and China were working to develop a vaccine and that Beijing had handed over the

“This is insane,” Adam Kamradt-Scott, associate professor specializing in global health security at the University of Sydney, says of China’s gung-ho vaccine rollout. “It is just unsound public health practice. We have previous examples of where vaccines that have not gone through sufficient clinical trials have demonstrated adverse reactions with long-term health consequences.”

As the coronavirus pandemic approaches its 11th month, with over 40 million cases and 1.1 million deaths globally, longing for a miracle cure becomes more desperate. But the consequences of a vaccine misstep could also be dire. In 1976, a rushed campaign to immunize millions of Americans against swine flu subsequently resulted in a small proportion developing chronic fatigue syndrome and helped spark the modern anti-vaxxer movement. Handing out a pre-approval vaccine without sufficient monitoring of efficacy and health of participants risks stoking public misinformation.

States prepare for their own vaccine safety reviews amid worries about Trump’s influence on the FDA

  States prepare for their own vaccine safety reviews amid worries about Trump’s influence on the FDA It's not yet clear whether the states would seek to block distribution of a vaccine they deem unsafe or ineffective, or just broadcast those concerns far and wide.New York, California, Michigan, West Virginia, Washington D.C. and potentially a handful of others are in the early stages of creating independent panels to review vaccine data as it becomes available – although it’s not yet clear whether all these states would seek to block distribution of a vaccine they deem unsafe or ineffective, or just to broadcast those concerns.

Covid - 19 vaccine , a new government poll has revealed that just 23 percent of the nation wants to The hesitance of Russians to be injected is mainly linked to the lack of proof that any vaccine Fyodor Lisitsyn announced that the country's homegrown Sputnik V vaccine may begin its roll out at the end

“If people are getting exposed, and they’re not getting tested, and they’re not isolating, that’s a huge problem,” one doctor said.Credit Adriana Zehbrauskas for The New York Times.

Read more: How an Election-Year Vaccine Rollout in 1976 Backfired

What’s more, since COVID-19 cases are so low in China, Stage 3 trials—when the vaccine is given thousands to see how many become infected, compared with volunteers who received a placebo—can only be conducted overseas. There have also not been any “challenge” trials where scientists deliberately expose vaccinated volunteers to the virus to test immunity. (Although controversial, such trials are about to go ahead in the U.K.)

But it’s not just China that’s getting ahead of itself. U.S. President Donald Trump has put enormous public pressure on regulators and pharmaceutical companies to make a vaccine available in time for the American election. On Oct. 16, Pfizer revealed it may begin rolling out its vaccine for emergency use in the U.S. by late November. Moderna has a similar timeline for emergency use, though cautions widespread vaccine distribution may not happen until the spring.

The difference in China, however, is that the virus has been largely contained domestically. The country reported only 14 cases on Wednesday, all imported. “It seems there is no need to get a vaccine in China,” says the student Li. “After all, the pandemic has little impact on life in China now; even masks are not mandatory here anymore.”

Westminster Dog Show, Surgeon General cited, Las Vegas casino to debut: News from around our 50 states

  Westminster Dog Show, Surgeon General cited, Las Vegas casino to debut: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

RT.com supports Covid - 19 testing and other widely-adopted public health measures developed to fight the pandemic. It turns out that tests that deliver a simple binary “positive or negative” result are not fit for purpose, as they tell us nothing about the contagiousness of each person.

Chinese hospitals overflowing with COVID - 19 patients a few weeks ago now have empty beds. “Hundreds of thousands of people in China did not get COVID - 19 because of this aggressive response.” There are really practical things you can do to be ready to be able to respond to this

So why is China so aggressively rolling out vaccines? For the Beijing government, the fight against the pandemic has become a PR battle to drown out international criticism about its early mishandling, coverup and silencing of whistleblowers. Instead, China wants to rebrand itself as a source of vital PPE and, ultimately, a solution the crisis. China’s National Health Authority projected China’s COVID-19 vaccine production capacity will reach 610 million doses annually by the end of 2020. SinoPharm’s boss says his firm alone may be able to produce more than 1 billion doses next year.

Read more: Inside the Unprecedented Scramble to Immunize the World Against COVID-19

Sinovac has promised to supply 40 million CoronaVac doses to Indonesia by March 2021. São Paulo Governor João Doria said Brazil’s federal government had also agreed to buy 46 million doses of CoronaVac, one of at least five vaccines undergoing stage 3 trials in the country, which has the world’s third highest infection tally.

“The first results of the clinical study conducted in Brazil prove that among all the vaccines tested in the country, CoronaVac is the safest, the one with the best and most promising rates,” Doria told reporters Monday.

Of course, China is not alone in craving the PR benefits. On Aug. 11, Russian President Vladimir Putin unveiled what was ostensibly the world’s first COVID-19 vaccine, which he said had already been administered to his daughter. The trade name—Sputnik 5, after the groundbreaking Soviet satellite—leaves no doubt at the national pride wrapped in its development. But it was tested on only 76 people—38 in Phase I and 38 in Phase II trials—and hadn’t even entered phrase 3 trials. The vaccine hasn’t stopped COVID-19 from spiking to record levels in the country this month.

“My gut reaction is that this is China’s attempt to claim international prestige by being first to rollout a widespread vaccination program,” says Kamradt-Scott, the Australian global health expert. “Unfortunately, I just see politics at play here rather than public health.”

Justin Turner tests positive for COVID-19, removed from Game 6 .
Justin Turner was pulled from Game 6 of the World Series after seven innings on Tuesday night, and the world found out the shocking reason why: Turner tested positive for COVID-19. © Tim Heitman-USA TODAY Sports Turner started and began the game for the Los Angeles Dodgers as the No. 3 hitter and third baseman. But he was pulled before the start of the eighth, with Enrique Hernandez going to second, Chris Taylor moving to left, and Edwin Rios playing third.There was no explanation for why Turner was removed until after the Dodgers won the World Series 3-1.

usr: 0
This is interesting!